DoD Rare Cancers, Concept Award
ID: 358793Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/358793
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research Acquisition Activity (USAMRAA), is offering a grant opportunity under the FY25 Rare Cancers Research Program (RCRP) Concept Award, aimed at funding innovative research focused on rare cancers. This program seeks to support groundbreaking, untested studies that can potentially lead to new avenues of investigation in the field, particularly benefiting active-duty service members, veterans, military beneficiaries, and the general public. With an estimated total funding of approximately $2.38 million, individual applications can request up to $140,000, and the performance period for funded projects is capped at two years. Interested applicants must submit a Letter of Intent by July 22, 2025, followed by a full application due by August 26, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942525RCRPCA_GG.pdf
    The FY25 Rare Cancers Research Program Concept Award provides funding for innovative research focused on rare cancers, defined as those affecting six or fewer individuals per 100,000 annually in the U.S. The U.S. Army Medical Research Acquisition Activity (USAMRAA) administers this program. Proposed studies should be groundbreaking, untested, and relevant for active-duty service members, veterans, military beneficiaries, and the general public. The total funding available is approximately $2.38 million, with a cap of $140,000 per application and a maximum performance period of two years. The submission process involves a two-step application: first, a Letter of Intent due by July 22, 2025, and then a full application by August 26, 2025. Eligibility extends to various organizations and institutions, including non-profit, for-profit, domestic, and foreign entities, provided that their principal investigators meet specific criteria. Funds cannot be used for clinical trials or travel beyond specified limits. Passing both peer and programmatic review processes is necessary for securing funding, ensuring that proposals align with the program’s mission to advance rare cancer research. Overall, this award aims to inspire high-risk, high-reward research initiatives in the field of rare cancers.
    Similar Opportunities
    DoD Rare Cancers, Idea Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering a funding opportunity for the Rare Cancers Research Program (RCRP) Idea Development Award for fiscal year 2025. This grant aims to support innovative research that explores new ideas and develops impactful strategies in the area of rare cancers, which are defined as those affecting six or fewer individuals per 100,000 annually in the U.S. Eligible applicants include various organizations, and the program encourages interdisciplinary collaboration among military, academic, and industry sectors to enhance health outcomes for military Service Members, Veterans, and the broader public. The total estimated program funding is $6,860,000, with a funding limit of $490,000 per application. Key deadlines include a pre-application due by July 1, 2025, and a full application by October 6, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DoD Rare Cancers, Resource and Community Development Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Rare Cancers Research Program Resource and Community Development Award, with an estimated total funding of $5.6 million aimed at enhancing research resources and clinical data related to rare cancers. This grant seeks to address critical gaps in rare cancer research, including the lack of resources, communication strategies, and data-sharing infrastructure, while emphasizing the integration of patient advocates throughout the project lifecycle. Eligible applicants include both domestic and foreign non-profit and for-profit organizations, with applications due by October 6, 2025, following a pre-application deadline of July 1, 2025. For further inquiries, interested parties can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    DOD Peer Reviewed Cancer, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the fiscal year 2025 Peer Reviewed Cancer Research Program (PRCRP) Idea Award to support innovative cancer research that prioritizes military health. This grant aims to fund high-risk, high-reward proposals that focus on specific cancer types relevant to Service Members, Veterans, and their families, with an emphasis on introducing new paradigms in cancer care and addressing environmental exposure risks. With an estimated total program funding of approximately $14 million, the program anticipates awarding around 25 projects, each with a maximum funding limit of $560,000 for a duration of up to two years. Interested applicants must submit a pre-application by June 20, 2025, followed by a full application due by September 25, 2025; for further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity for the fiscal year 2025 under the Peer Reviewed Cancer Research Program (PRCRP) Clinical Trial Award (CTA). This grant aims to support the rapid implementation of clinical trials that have the potential to significantly impact cancer treatment, specifically targeting designated cancer types relevant to military health. The program emphasizes the importance of advancing cancer research to benefit service members, veterans, and their families, with funding available for projects ranging from initial proof-of-concept trials to large-scale phase III trials, capped at a total cost of $4.2 million over a maximum performance period of four years. Interested applicants must submit pre-applications by June 20, 2025, followed by full applications due by September 25, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DOD Peer Reviewed Cancer, Impact Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Impact Award to support high-impact research aimed at improving clinical cancer care relevant to military health. This grant seeks mature research projects that demonstrate potential for near-term benefits in cancer treatment and patient outcomes, particularly focusing on specific cancer types such as bladder, blood, and brain cancers, while excluding melanoma and breast cancers. The program emphasizes the importance of preliminary data, collaboration with Department of Defense (DOD) and Veterans Affairs (VA) entities, and rigorous study designs to advance cancer detection and treatment for service members and their families. The estimated total program funding is $45.5 million, with individual awards capped at $1.4 million for single Principal Investigator applications and $1.75 million for partnering applications, over a maximum period of three years. Interested applicants must submit a pre-application by September 25, 2025, and can contact the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Melanoma, Focused Program Award – Rare Melanomas
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a funding opportunity for the DoD Melanoma, Focused Program Award aimed at advancing research on rare melanomas. This grant supports multidisciplinary teams to propose two to three complementary research projects centered around a common overarching question related to rare melanomas, with an emphasis on collaboration among Principal Investigators (PIs) from various institutions. The total funding available is $6.4 million, with approximately two awards expected, each providing up to $2 million over a maximum four-year period. Interested applicants must submit a pre-application by June 30, 2025, and, if invited, a full application by October 1, 2025. For further inquiries, contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Career Development Award – Fellow and Resident Option
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Peer Reviewed Cancer Research Program (PRCRP) Career Development Award, specifically targeting early-career researchers via Fellow and Resident Options. This grant aims to support advancements in cancer research by funding projects that address critical issues relevant to military health, with a focus on specific PRCRP topic areas such as blood, gastroenterological, and neurological cancers. The total estimated funding for this initiative is approximately $6.72 million, with funding caps of $280,000 for one-year Resident projects and $560,000 for three-year Fellow projects. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025, and can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.
    DoD Peer Reviewed Medical Research Program, Clinical Trial Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering a grant opportunity under the Peer Reviewed Medical Research Program (PRMRP) for the fiscal year 2025, specifically for the Clinical Trial Award (CTA). This program aims to support the rapid implementation of clinical trials that can significantly impact the treatment or management of diseases relevant to military health, with a focus on areas such as autoimmune disorders, cardiovascular health, infectious diseases, and neuroscience. Approximately $32 million is available for this initiative, with an expected four awards, each capped at $8 million, and applications are due by July 21, 2025. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507 for further assistance.
    DoD Melanoma, Idea Award
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the FY25 Melanoma Research Program Idea Award to support innovative and exploratory research related to melanoma. This grant aims to fund high-risk, potentially high-reward projects that focus on areas such as melanoma prevention, rare melanoma research, or survivorship impacts, with a maximum direct cost of $400,000 available for each project over a two-year period. The program is particularly significant for advancing melanoma detection, treatment, and survivorship, especially in the context of military health concerns. Interested applicants must submit a pre-application by June 30, 2025, followed by a full application due by October 1, 2025, with a total funding pool of approximately $5.76 million available for about nine awards. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.
    DOD Peer Reviewed Cancer, Career Development Award – Scholar Option
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research and Development Command (USAMRAA), is offering the Peer Reviewed Cancer Research Program (PRCRP) Career Development Award – Scholar Option (CDA-SO) for fiscal year 2025. This grant aims to support independent early-career investigators, referred to as Scholars, in conducting impactful cancer research under the mentorship of an experienced Career Guide, with a focus on military health-related cancer issues. The program has an estimated total funding of approximately $9.9 million, with about nine awards anticipated, each capped at $1.1 million. Interested applicants must submit a pre-application by June 19, 2025, followed by a full application due by July 3, 2025. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or call 301-682-5507.